Skip to main content
    Q

    Q32 Bio Inc (QTTB)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $8.29
    -0.42 (-4.82%)

    Market Cap: $260.64M

    Last updated: Nov 17, 2026 at 11:06 AM ET

    Q32 Bio Inc (QTTB) Earnings: Report Dates and Results

    Updated Nov 4, 2026. Results come from company earnings reports, and estimates are consensus analyst estimates.

    Q32 Bio (QTTB) is expected to report earnings on May 3, 2027. In the quarter ended Sep 30, 2026, Q32 Bio reported EPS of -$0.26, above the -$0.36 estimate. It beat the EPS estimate in each of the last 8 quarters.

    Earnings

    Performance (10Y)

    Beat Rate
    58%(19/33)
    Avg Surprise
    +30.46%
    Streak
    8 Q

    Upcoming Estimates

    Report date not yet scheduledPeriod ending Dec 31, 2026
    EPS Consensus-$0.31
    Range-$0.36 - -$0.24
    10 analysts
    Revenue Consensus
    N/A
    RangeN/A
    8 analysts
    Reports May 3, 2027 (est.)Period ending Mar 31, 2027
    EPS Consensus-$0.42
    Range-$0.43 - -$0.40
    2 analysts
    EPS Revisions
    1
    0
    30d
    EPS Estimate DriftChange to current
    90d ago-$0.34-23.9%
    60d ago-$0.34-23.9%
    30d ago-$0.40-3.7%
    7d ago-$0.41-1.2%
    Current-$0.42
    Revenue Consensus
    N/A
    RangeN/A
    3 analysts

    Next Report

    QTTB has an expected report date of May 3, 2027.

    Earnings History

    Of the 33 quarters below that had an estimate, QTTB beat 19 and missed 14. The widest gap in the table came in the quarter ended Dec 31, 2025, when EPS landed 632.56% above the estimate.

    Quarter endedEPSEstimateRangeSurpriseResultYoYAnalystsRevisionsReportedRevenue
    Sep 30, 2026-$0.26-$0.36-$0.42 - -$0.27+27.78%BeatN/A72 up, 1 downNov 4, 2026N/A
    Jun 30, 2026-$0.44-$0.53-$0.61 - -$0.48+16.98%BeatN/A50 up, 0 downAug 5, 2026N/A
    Mar 31, 2026-$0.54-$0.68-$0.84 - -$0.52+20.59%BeatN/A20 up, 0 downMay 5, 2026N/A
    Dec 31, 2025$4.58-$0.86-$1.06 - -$0.63+632.56%BeatN/A31 up, 0 downMar 10, 2026$53.74M
    Sep 30, 2025-$0.60-$1.19-$1.39 - -$0.99+49.58%BeatN/A20 up, 0 downNov 13, 2025N/A
    Jun 30, 2025-$0.78-$0.98N/A+20.41%BeatN/AN/A0 up, 0 downAug 6, 2025N/A
    Mar 31, 2025-$0.90-$1.23N/A+26.83%Beat-187.4%N/A0 up, 0 downMay 8, 2025N/A
    Dec 31, 2024-$1.16-$1.53N/A+24.18%BeatN/AN/A0 up, 0 downMar 11, 2025N/A
    Sep 30, 2024-$1.46-$1.45-$1.59 - -$1.00-0.69%MissN/A50 up, 0 downNov 7, 2024N/A
    Jun 30, 2024-$1.42-$1.04N/A-36.54%MissN/AN/AN/AAug 8, 2024N/A
    Mar 31, 2024$1.03-$1.41N/A+173.05%BeatN/AN/AN/AMay 9, 2024N/A
    Dec 31, 2023-$0.28-$0.30N/A+6.67%BeatN/AN/AN/AMar 13, 2024N/A
    Sep 30, 2023-$0.57-$0.43N/A-32.56%MissN/AN/AN/ANov 14, 2023$1.86M
    Jun 30, 2023-$0.61-$0.50N/A-22.00%MissN/AN/AN/AJul 27, 2023$3.21M
    Mar 31, 2023-$0.50-$0.52N/A+3.85%Beat-101.7%N/AN/AMay 11, 2023$2.95M
    Dec 31, 2022-$10.80-$8.85N/A-22.00%MissN/AN/AN/AMar 29, 2023$802000
    Sep 30, 2022-$10.62-$8.21N/A-29.38%MissN/AN/AN/ADec 29, 2022$802000
    Jun 30, 2022-$9.18-$9.67N/A+5.06%BeatN/AN/AN/ASep 28, 2022$802000
    Mar 31, 2022$28.62-$0.49N/AN/AN/AN/AN/AN/AJun 28, 2022$802000
    Dec 31, 2021-$10.62-$10.33N/A-2.80%MissN/AN/AN/AMar 29, 2022$802000
    Sep 30, 2021-$9.72-$10.56N/A+7.93%BeatN/AN/AN/ADec 29, 2021$1.68M
    Jun 30, 2021-$9.72-$10.34N/A+6.01%BeatN/AN/AN/ASep 28, 2021$2.19M
    Mar 31, 2021-$0.36-$0.61N/A+41.35%BeatN/AN/AN/AJun 28, 2021$29.30M
    Dec 31, 2020-$11.16-$11.85N/A+5.81%BeatN/AN/AN/AMar 30, 2021$980000
    Sep 30, 2020-$11.16-$0.81N/AN/AN/AN/AN/AN/ANov 9, 2020$567000
    Jun 30, 2020-$14.04-$13.31N/A-5.49%MissN/AN/AN/AAug 10, 2020$567000
    Mar 31, 2020-$14.04-$12.41N/A-13.13%MissN/AN/AN/AJun 29, 2020$588000
    Dec 31, 2019-$9.90-$12.23N/A+19.05%BeatN/AN/AN/AMar 30, 2020$563000
    Sep 30, 2019-$12.06-$10.79N/A-11.76%MissN/AN/AN/ANov 12, 2019$441000
    Jun 30, 2019-$10.98-$9.89N/A-11.00%MissN/AN/AN/AAug 8, 2019$392000
    Mar 31, 2019-$11.52-$9.71N/A-18.61%MissN/AN/AN/AJun 29, 2019$270000
    Dec 31, 2018-$9.18-$7.91N/A-16.00%MissN/AN/AN/AMar 30, 2019$1.20M
    Sep 30, 2018-$7.20-$6.65N/A-8.19%MissN/AN/AN/ANov 13, 2018$1.60M
    Jun 30, 2018-$0.16-$0.33N/A+51.52%BeatN/AN/AN/AAug 13, 2018$1.40M
    Mar 31, 2018-$0.15-$3.78N/A+96.03%BeatN/AN/AN/AJun 29, 2018$1.13M
    Dec 31, 2017-$0.32N/AN/AN/AN/AN/AN/AN/AMar 30, 2018N/A
    Last 36 quarters

    Estimates made before a stock split are shown on the same share basis as the reported EPS.

    Annual EPS

    EPS for the fiscal year ended Dec 31, 2025 was $2.30, a profit after a loss of $3.01 per share the year before. It was -$0.32 for the year ended Dec 31, 2017, the oldest of the 9 fiscal years shown.

    Fiscal year endedEPSChange
    Dec 31, 2025$2.30N/A
    Dec 31, 2024-$3.01N/A
    Dec 31, 2023-$1.96N/A
    Dec 31, 2022-$1.98N/A
    Dec 31, 2021-$30.42N/A
    Dec 31, 2020-$50.40N/A
    Dec 31, 2019-$44.46N/A
    Dec 31, 2018-$16.69N/A
    Dec 31, 2017-$0.32N/A

    Frequently Asked Questions About QTTB

    When is Q32 Bio's next earnings date?

    Q32 Bio's next earnings report is expected for May 3, 2027.

    Did QTTB beat earnings estimates last quarter?

    Yes. Q32 Bio reported EPS of -$0.26 for the quarter ended Sep 30, 2026, above the -$0.36 estimate, a 27.78% surprise.

    What EPS do analysts expect from QTTB next quarter?

    The consensus EPS estimate for Q32 Bio for the quarter ending Dec 31, 2026 is -$0.31 from 10 analysts, with estimates from -$0.36 to -$0.24.

    How often does QTTB beat earnings estimates?

    Q32 Bio beat the EPS estimate in each of the last 8 quarters, with an average surprise of +102.36%.